首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
【24h】

5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.

机译:5-硝基-2-呋喃基衍生物对克鲁斯锥虫的活性:体内初步研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Ten 5-nitro-2-furyl derivatives, with good to excellent in vitro anti-Trypanosoma cruzi activity, and nifurtimox were tested oral and intraperitoneally on healthy animals for its acute toxicity on murine models. According to animals' survival percentage, organ histological results, biochemical and haematological findings, three new derivatives, with toxicity like nifurtimox, were selected to test in vivo as antichagasic agents. Clearly, dependences between chemical structure and both acute toxicity and in vivo anti-T. cruzi activity were observed. 4-Hexyl-1-[3-(5-nitro-2-furyl)-2-propenylidene]semicarbazide displayed good profile as anti-T. cruzi agent and better acute toxicity profile than nifurtimox.
机译:在健康动物中口服和腹膜内测试了十种具有良好或优异的体外抗克氏锥虫活性的5-硝基-2-呋喃基衍生物和硝呋替莫,以证明它们对鼠模型具有急性毒性。根据动物的存活率,器官组织学结果,生化和血液学发现,选择了三种具有毒性的新衍生物,如硝呋替莫斯(nifurtimox),作为抗chachagasic剂进行体内测试。显然,化学结构与急性毒性和体内抗T之间存在依赖性。观察到了克鲁兹活性。 4-己基-1- [3-(5-硝基-2-呋喃基)-2-丙烯基]氨基脲显示出良好的抗T特性。与尼呋替莫相比,它具有克鲁索剂和更好的急性毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号